These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3471667)

  • 1. Family analysis for IDDM--HLA. Comparison of the two-allele model versus the three-allele model.
    Neugebauer M; Bertrams J; Baur MP
    Genet Epidemiol Suppl; 1986; 1():335-40. PubMed ID: 3471667
    [No Abstract]   [Full Text] [Related]  

  • 2. HLA and IDDM predisposition: new aspects.
    Thomson G; Klitz W; Louis EJ; Lo SK; Bertrams J; Baur M; Neugebauer M
    Genet Epidemiol Suppl; 1986; 1():363-8. PubMed ID: 3471669
    [No Abstract]   [Full Text] [Related]  

  • 3. HLA-DR effects in a large German IDDM dataset.
    Field LL; Fothergill-Payne C; Bertrams J; Baur MP
    Genet Epidemiol Suppl; 1986; 1():323-8. PubMed ID: 3471665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA haplotype sharing and proband genotype in IDDM.
    Rotter JI; Vadheim CM; Petersen GM; Cantor RM; Riley WJ; Maclaren NK
    Genet Epidemiol Suppl; 1986; 1():347-52. PubMed ID: 3569864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing the simple 3-allele model of inheritance of IDDM at the HLA-associated locus.
    Greenberg DA
    Genet Epidemiol Suppl; 1986; 1():329-34. PubMed ID: 3471666
    [No Abstract]   [Full Text] [Related]  

  • 6. A combined segregation and linkage analysis of insulin-dependent diabetes mellitus.
    Rich SS
    Genet Epidemiol Suppl; 1986; 1():341-6. PubMed ID: 3569863
    [No Abstract]   [Full Text] [Related]  

  • 7. HLA haplotype sharing in IDDM affected sib pairs as a function of HLA DR genotype.
    Falk CT
    Genet Epidemiol Suppl; 1986; 1():353-8. PubMed ID: 3471668
    [No Abstract]   [Full Text] [Related]  

  • 8. A synergistic three allele model for the HLA-linked components of coeliac disease predisposition.
    Louis EJ; Payami H; Klitz W; Lo SK; Thomson G
    Genet Epidemiol Suppl; 1986; 1():277-82. PubMed ID: 3569858
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic analysis workshop IV: insulin dependent diabetes mellitus--summary.
    Baur MP
    Genet Epidemiol Suppl; 1986; 1():299-312. PubMed ID: 3471663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of HLA with diseases in Japanese.
    Naito S
    Jinrui Idengaku Zasshi; 1986 Dec; 31(4):323-9. PubMed ID: 3302425
    [No Abstract]   [Full Text] [Related]  

  • 11. Implication of HLA-DMA alleles in corsican IDDM.
    Cucchi-Mouillot P; Lai S; Carcassi C; Sorba P; Stuart-Simoni M; Amoros JP; Genetet B; Haras D; Contu L
    Dis Markers; 1998 Nov; 14(3):135-41. PubMed ID: 10427471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrimination between genetic models for insulin dependent diabetes mellitus.
    Clerget-Darpoux F; Dizier MH; Bonaïti-Pellié C; Babron MC; Hochez J; Martinez M
    Genet Epidemiol Suppl; 1986; 1():313-8. PubMed ID: 3471664
    [No Abstract]   [Full Text] [Related]  

  • 13. Linkage and association of the HLA gene complex with IDDM in 81 Danish families: strong linkage between DR beta 1Lys71+ and IDDM.
    Zamani M; Pociot F; Spaepen M; Raeymaekers P; Nerup J; Cassiman JJ
    J Med Genet; 1996 Nov; 33(11):899-905. PubMed ID: 8950668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Class I HLA is associated with age-at-onset of IDDM, while class II HLA confers susceptibility to IDDM.
    Fujisawa T; Ikegami H; Kawaguchi Y; Yamato E; Takekawa K; Nakagawa Y; Hamada Y; Ueda H; Shima K; Ogihara T
    Diabetologia; 1995 Dec; 38(12):1493-5. PubMed ID: 8786033
    [No Abstract]   [Full Text] [Related]  

  • 15. Absence of HLA linkage in a family with osteitis deformans (Paget's disease of bone).
    Breanndan Moore S; Hoffman DL
    Tissue Antigens; 1988 Feb; 31(2):69-70. PubMed ID: 3163858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell-defined DR4 subtypes as markers for type 1 diabetes.
    Rowe JR; Mickelson EM; Hansen JA; MacDonald MJ; Allen CI; Gabbay KH; Yunis EJ; Sheehy MJ
    Hum Immunol; 1988 May; 22(1):51-60. PubMed ID: 3260586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA and genetics of IDDM. Holism vs. reductionism?
    Segall M
    Diabetes; 1988 Aug; 37(8):1005-8. PubMed ID: 3292321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles.
    Sheehy MJ; Scharf SJ; Rowe JR; Neme de Gimenez MH; Meske LM; Erlich HA; Nepom BS
    J Clin Invest; 1989 Mar; 83(3):830-5. PubMed ID: 2784133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenetics of HLA class II in Israeli Ashkenazi Jewish, Israeli non-Ashkenazi Jewish, and in Israeli Arab IDDM patients.
    Kwon OJ; Brautbar C; Weintrob N; Sprecher E; Saphirman C; Bloch K; Pinhas-Hamiel O; Assah S; Vardi P; Israel S
    Hum Immunol; 2001 Jan; 62(1):85-91. PubMed ID: 11165718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of HLA-B allele on the IDDM risk defined by DRB1*04 subtypes and DQB1*0302.
    Nejentsev S; Reijonen H; Adojaan B; Kovalchuk L; Sochnevs A; Schwartz EI; Akerblom HK; Ilonen J
    Diabetes; 1997 Nov; 46(11):1888-92. PubMed ID: 9356041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.